ARCHIVES

Oblimersen Combination Improves CLL Survival

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

American Home Products Changes Name To Wyeth.

March 1, 2002

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011